Report Detail

Pharma & Healthcare Global Seasonal Influenza Vaccines Market Insights and Forecast to 2026

  • RnM4114838
  • |
  • 05 August, 2020
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Seasonal Influenza Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Seasonal Influenza Vaccines market is segmented into
Type A (H1N1)
Type A (H3N2)
Type B

Segment by Application, the Seasonal Influenza Vaccines market is segmented into
Pediatrics
Adolescence
Adults
Elderly

Regional and Country-level Analysis
The Seasonal Influenza Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Seasonal Influenza Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Seasonal Influenza Vaccines Market Share Analysis
Seasonal Influenza Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Seasonal Influenza Vaccines business, the date to enter into the Seasonal Influenza Vaccines market, Seasonal Influenza Vaccines product introduction, recent developments, etc.

The major vendors covered:
GlaxoSmithKline plc
Sinovac Biotech Ltd
Changsheng Bio-Technology
Ccbio SA
Aleph Biomedical
Sanofi
Jiangsu Simcere Vaxtec Bio-pharmaceutical
Dalian Hissen Bio-pharm
Abbott Laboratories
Novartis International AG


1 Study Coverage

  • 1.1 Seasonal Influenza Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Seasonal Influenza Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type
    • 1.4.2 Type A (H1N1)
    • 1.4.3 Type A (H3N2)
    • 1.4.4 Type B
  • 1.5 Market by Application
    • 1.5.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Application
    • 1.5.2 Pediatrics
    • 1.5.3 Adolescence
    • 1.5.4 Adults
    • 1.5.5 Elderly
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Seasonal Influenza Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Seasonal Influenza Vaccines Revenue 2015-2026
    • 2.1.2 Global Seasonal Influenza Vaccines Sales 2015-2026
  • 2.2 Global Seasonal Influenza Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Seasonal Influenza Vaccines Competitor Landscape by Players

  • 3.1 Seasonal Influenza Vaccines Sales by Manufacturers
    • 3.1.1 Seasonal Influenza Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Seasonal Influenza Vaccines Revenue by Manufacturers
    • 3.2.1 Seasonal Influenza Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Seasonal Influenza Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Seasonal Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Revenue in 2019
    • 3.2.5 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Seasonal Influenza Vaccines Price by Manufacturers
  • 3.4 Seasonal Influenza Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Seasonal Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Seasonal Influenza Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Seasonal Influenza Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Seasonal Influenza Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Seasonal Influenza Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Seasonal Influenza Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Seasonal Influenza Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Seasonal Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Seasonal Influenza Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Seasonal Influenza Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Seasonal Influenza Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Seasonal Influenza Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Seasonal Influenza Vaccines Price by Application (2015-2020)
  • 5.2 Seasonal Influenza Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Seasonal Influenza Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Seasonal Influenza Vaccines by Country
    • 6.1.1 North America Seasonal Influenza Vaccines Sales by Country
    • 6.1.2 North America Seasonal Influenza Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Seasonal Influenza Vaccines Market Facts & Figures by Type
  • 6.3 North America Seasonal Influenza Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Seasonal Influenza Vaccines by Country
    • 7.1.1 Europe Seasonal Influenza Vaccines Sales by Country
    • 7.1.2 Europe Seasonal Influenza Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Seasonal Influenza Vaccines Market Facts & Figures by Type
  • 7.3 Europe Seasonal Influenza Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Seasonal Influenza Vaccines by Region
    • 8.1.1 Asia Pacific Seasonal Influenza Vaccines Sales by Region
    • 8.1.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Seasonal Influenza Vaccines by Country
    • 9.1.1 Latin America Seasonal Influenza Vaccines Sales by Country
    • 9.1.2 Latin America Seasonal Influenza Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Seasonal Influenza Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America Seasonal Influenza Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Seasonal Influenza Vaccines by Country
    • 10.1.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country
    • 10.1.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GlaxoSmithKline plc
    • 11.1.1 GlaxoSmithKline plc Corporation Information
    • 11.1.2 GlaxoSmithKline plc Description and Business Overview
    • 11.1.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products Offered
    • 11.1.5 GlaxoSmithKline plc Related Developments
  • 11.2 Sinovac Biotech Ltd
    • 11.2.1 Sinovac Biotech Ltd Corporation Information
    • 11.2.2 Sinovac Biotech Ltd Description and Business Overview
    • 11.2.3 Sinovac Biotech Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Products Offered
    • 11.2.5 Sinovac Biotech Ltd Related Developments
  • 11.3 Changsheng Bio-Technology
    • 11.3.1 Changsheng Bio-Technology Corporation Information
    • 11.3.2 Changsheng Bio-Technology Description and Business Overview
    • 11.3.3 Changsheng Bio-Technology Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Products Offered
    • 11.3.5 Changsheng Bio-Technology Related Developments
  • 11.4 Ccbio SA
    • 11.4.1 Ccbio SA Corporation Information
    • 11.4.2 Ccbio SA Description and Business Overview
    • 11.4.3 Ccbio SA Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Ccbio SA Seasonal Influenza Vaccines Products Offered
    • 11.4.5 Ccbio SA Related Developments
  • 11.5 Aleph Biomedical
    • 11.5.1 Aleph Biomedical Corporation Information
    • 11.5.2 Aleph Biomedical Description and Business Overview
    • 11.5.3 Aleph Biomedical Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Aleph Biomedical Seasonal Influenza Vaccines Products Offered
    • 11.5.5 Aleph Biomedical Related Developments
  • 11.6 Sanofi
    • 11.6.1 Sanofi Corporation Information
    • 11.6.2 Sanofi Description and Business Overview
    • 11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Sanofi Seasonal Influenza Vaccines Products Offered
    • 11.6.5 Sanofi Related Developments
  • 11.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
    • 11.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
    • 11.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
    • 11.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Products Offered
    • 11.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Related Developments
  • 11.8 Dalian Hissen Bio-pharm
    • 11.8.1 Dalian Hissen Bio-pharm Corporation Information
    • 11.8.2 Dalian Hissen Bio-pharm Description and Business Overview
    • 11.8.3 Dalian Hissen Bio-pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Products Offered
    • 11.8.5 Dalian Hissen Bio-pharm Related Developments
  • 11.9 Abbott Laboratories
    • 11.9.1 Abbott Laboratories Corporation Information
    • 11.9.2 Abbott Laboratories Description and Business Overview
    • 11.9.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Abbott Laboratories Seasonal Influenza Vaccines Products Offered
    • 11.9.5 Abbott Laboratories Related Developments
  • 11.10 Novartis International AG
    • 11.10.1 Novartis International AG Corporation Information
    • 11.10.2 Novartis International AG Description and Business Overview
    • 11.10.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Novartis International AG Seasonal Influenza Vaccines Products Offered
    • 11.10.5 Novartis International AG Related Developments
  • 11.1 GlaxoSmithKline plc
    • 11.1.1 GlaxoSmithKline plc Corporation Information
    • 11.1.2 GlaxoSmithKline plc Description and Business Overview
    • 11.1.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products Offered
    • 11.1.5 GlaxoSmithKline plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Seasonal Influenza Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global Seasonal Influenza Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Seasonal Influenza Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America Seasonal Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: Seasonal Influenza Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: Seasonal Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: Seasonal Influenza Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Seasonal Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Seasonal Influenza Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: Seasonal Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Seasonal Influenza Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Seasonal Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Seasonal Influenza Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Seasonal Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Seasonal Influenza Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Seasonal Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Seasonal Influenza Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Seasonal Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Seasonal Influenza Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Seasonal Influenza Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Seasonal Influenza Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Seasonal Influenza Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Seasonal Influenza Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Seasonal Influenza Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Seasonal Influenza Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Seasonal Influenza Vaccines. Industry analysis & Market Report on Seasonal Influenza Vaccines is a syndicated market report, published as Global Seasonal Influenza Vaccines Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Seasonal Influenza Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,595.80
    5,393.70
    7,191.60
    595,764.00
    893,646.00
    1,191,528.00
    328,029.00
    492,043.50
    656,058.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report